Sort
48,018 grants matching “immunotherapy”
The c-Rel Checkpoint for Immunosuppression and Immunotherapy
$502,487Warren S Pear · University Of Pennsylvania · R01 · FY2024 · AI
The c-Rel Checkpoint for Immunosuppression and Immunotherapy
$502,487Warren S Pear · University Of Pennsylvania · R01 · FY2023 · AI
CD8+ T Cell Immunity to Cytomegalovirus
$502,469Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2009 · AI
Epitope-specific T cell activation to complement TB immunity and vaccine efficacy
$502,456Joel D. Ernst · New York University School Of Medicine · R56 · FY2014 · AI
Lineage heterogeneity and plasticity in lung cancer
$502,376Hideo Watanabe · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · CA
Enhancing neoadjuvant chemotherpay responses with targeted T cells
$502,349Lawrence G Lum · Wayne State University · R01 · FY2011 · CA
SUMO Modification and Cancer Therapy
$502,341Yuan Chen · University Of California, San Diego · R01 · FY2022 · CA
Transcriptional and metabolic regulation of Treg cell specification for the control of allergic airway disease
$502,332Kai Yang · Indiana University Indianapolis · R01 · FY2022 · AI
Transcriptional and metabolic regulation of Treg cell specification for the control of allergic airway disease
$502,332Kai Yang · Indiana University Indianapolis · R01 · FY2025 · AI
Developmental Funds
$502,248Peter A Jones · University Of Southern California · P30 · FY2012 · CA
Acoustothermogenetics for Cell Engineering
$502,212Yingxiao Wang · University Of California, San Diego · R35 · FY2021 · GM
PROTEINS IN MULTIPLE MYELOMA AND RELATED BLOOD DISORDERS
$502,141Alan Solomon · University Of Tennessee Knoxville · R01 · FY2009 · CA
Project 1: Combinatorial adjuvants promote uniform and selective intratumoral CTL infiltration in colorectal cancer
$502,126Pawel Kalinski · Roswell Park Cancer Institute Corp · P01 · FY2023 · CA
IDO1 and Immunotolerance in Glioblastoma
$502,054Derek Alan Wainwright · Loyola University Chicago · R01 · FY2025 · NS
IND-Enabling Toxicology for a Novel Ca2+ Channel Therapeutic to Improve Outcomes Associated with Checkpoint Inhibitor Immunotherapy
$502,010Milton L Greenberg · Vivreon Biosciences, Llc · R44 · FY2024 · CA
SOUTHWEST ONCOLOGY GROUP
$501,965University Of Rochester · U10 · FY2003 · CA
Clinical translation of 19F MRI to visualize cancer immunotherapeutic cells
$501,962Eric T Ahrens · University Of California, San Diego · R01 · FY2019 · CA
Non-Human Primate and Imaging Core
$501,935Francois J Villinger · Northwestern University At Chicago · P01 · FY2017 · AI
Novel nano-vaccine technology for inducing immunity against gliomas
$501,930James J. Moon · University Of Michigan At Ann Arbor · R01 · FY2023 · NS
Novel nano-vaccine technology for inducing immunity against gliomas
$501,930James J. Moon · University Of Michigan At Ann Arbor · R01 · FY2021 · NS
Novel nano-vaccine technology for inducing immunity against gliomas
$501,930James J. Moon · University Of Michigan At Ann Arbor · R01 · FY2025 · NS
Novel nano-vaccine technology for inducing immunity against gliomas
$501,930James J. Moon · University Of Michigan At Ann Arbor · R01 · FY2022 · NS
Phase II Trial of HOKT3gamma 1 (ALA-ALA) in Type 1 Diabetes
$501,924Kevan C Herold · Yale University · R01 · FY2009 · DK
HPV genomic structure in cervical cancer radiation response and recurrence detection
$501,859Jin Zhang · Washington University · R37 · FY2025 · CA
Targeting immunoproteasome-mediated antigen presentation in colorectal cancer immunotherapy
$501,827Xinna Zhang · Indiana University Indianapolis · R01 · FY2025 · CA